RUNX1在系统性硬化症真皮成纤维细胞亚群中表达并与疾病严重程度相关
本研究利用SSc皮肤基因表达、全基因组DNA甲基化和单细胞数据,分析RUNX1失调在SSc真皮纤维化中的作用,并通过siRNA、药物抑制和CRISPR敲除在2D和3D成纤维细胞培养中评估RUNX1功能。结果显示RUNX1表达与SSc皮肤纤维化严重程度相关,RUNX1基因附近CpG位点低甲基化,单细胞RNA-seq显示RUNX1在SSc富集的成纤维细胞亚群中更高,抑制RUNX1可减少成纤维细胞活化、收缩、细胞外基质成分和增殖。
要点
- RUNX1表达与SSc皮肤纤维化严重程度相关
- RUNX1基因附近CpG位点低甲基化可能解释其表达升高
- 抑制RUNX1可减少成纤维细胞活化和细胞外基质成分
核心结论
- 本研究首次证明RUNX1在SSc真皮纤维化发病机制中的潜在作用。
- RUNX1与更严重的SSc纤维化相关,并与参与纤维化的真皮成纤维细胞亚群相关。
研究设计与样本
- 利用SSc皮肤和成纤维细胞的基因表达、全基因组DNA甲基化和单细胞分辨率数据进行分析。
- 通过siRNA、药物抑制和CRISPR敲除在2维和3维成纤维细胞培养中评估RUNX1功能。
主要发现
- 多个队列基因表达分析显示SSc患者皮肤中真皮纤维化严重程度与RUNX1表达水平相关。
- 表观基因组分析鉴定RUNX1基因附近低甲基化的5-胞嘧啶-磷酸-鸟嘌呤-3(CpG)位点,提示其可能参与RUNX1表达升高。
- SSc皮肤活检单细胞RNA-seq数据显示RUNX1在SSc富集的成纤维细胞亚群中更高,这些亚群被认为促进纤维化。
- RUNX1 CRISPR敲除导致α平滑肌肌动蛋白表达减少。
- 抑制RUNX1活性导致成纤维细胞活化、收缩、细胞外基质成分和增殖速率降低,包括SFRP4、LUM和COL1A1减少。
临床怎么用
- RUNX1表达水平可能与SSc皮肤纤维化严重程度相关,可作为评估疾病严重程度的潜在生物标志物。
- 靶向抑制RUNX1活性可能减少成纤维细胞活化和细胞外基质沉积,为SSc皮肤纤维化提供潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The activation of runt-related transcription factor 1 (RUNX1) in fibroblasts has been implicated in wound healing and fibrosis; however, the role of RUNX1 in the fibrotic progression of the autoimmune disease systemic sclerosis (SSc) remains known. METHODS: Leveraging gene expression, genome-wide DNA methylation, and single-cell resolution data of SSc skin and fibroblast, we analysed the impact of RUNX1 dysregulation in SSc dermal fibrosis. RUNX1 function was subsequently assessed using siRNA, pharmacologic inhibition, and CRISPR knockout in 2-dimensional and 3-dimensional fibroblast cultures. RESULTS: Analysis of gene expression in multiple cohorts demonstrated an association between the severity of dermal fibrosis and the expression levels of RUNX1 in the skin of patients with SSc. Epigenomic analyses of methylation identified hypomethylated 5-Cytosine-phosphate-Guanine-3 (CpG) sites proximal to the RUNX1 gene, implicating their potential role in the increased expression of RUNX1. Analysis of single-cell RNA-seq data from skin biopsies of individuals with SSc revealed that RUNX1 is higher in subpopulations of fibroblasts enriched in SSc, which are believed to contribute to fibrosis. RUNX1 CRISPR knockout resulted in reduced alpha smooth muscle actin expression. Inhibition of RUNX1 activity caused a reduction in fibroblast activation, contraction, extracellular matrix components, and proliferation rates, including a reduction in SFRP4, LUM, and COL1A1. CONCLUSIONS: This study is the first to demonstrate a potential role for RUNX1 in the pathogenesis of SSc dermal fibrosis. RUNX1 is associated with more severe SSc fibrosis and is associated with a subpopulation of dermal fibroblasts implicated in fibrosis.
引用
- Parvizi R, Gong Z, Jarnagin HC, et al. RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis. Ann Rheum Dis. 2025. PMID: 41381303. doi:10.1016/j.ard.2025.10.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。